Elixinol Global

Sydney, Australia Founded: 2017 • Age: 9 yrs
Hemp-derived CBD nutraceuticals are manufactured for health and fitness needs.

About Elixinol Global

Elixinol Global is a company based in Sydney (Australia) founded in 2017 by Paul Benhaim.. Elixinol Global has completed 1 acquisition, including CannaCare Health. Elixinol Global operates in a competitive market with competitors including Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and DEMECAN, among others.

  • Headquarter Sydney, Australia
  • Founders Paul Benhaim
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $34.72 M (USD), Post-IPO

    Jun 13, 2019

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Elixinol Global

Elixinol Global is a publicly listed company on the ASX with ticker symbol EXL in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: EXL . Sector: Health technology · Australia

Funding Insights of Elixinol Global

  • Total Funding
  • Total Rounds 2
  • Last Round Post-IPO — $34.7M
  • First Round

    (28 Sep 2018)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2019 Amount Post-IPO - Elixinol Global Valuation

investors

Sep, 2018 Amount Post-IPO - Elixinol Global Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Elixinol Global

Elixinol Global has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CannaCare Health. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Cannabidiol products are manufactured and distributed to pharmacies.
2018
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Elixinol Global

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Elixinol Global Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Elixinol Global

Elixinol Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and DEMECAN, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cannabis plants are cultivated in greenhouses for wellness product development.
domain founded_year HQ Location
Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology.
domain founded_year HQ Location
Cannabis-infused products are developed, manufactured, and distributed for consumers.
domain founded_year HQ Location
Cannabis-derived nutritional and wellness products are offered online.
domain founded_year HQ Location
Producer of medical cannabis
domain founded_year HQ Location
Online marketplace for cannabis products treating various diseases is operated.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Elixinol Global

Frequently Asked Questions about Elixinol Global

When was Elixinol Global founded?

Elixinol Global was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Elixinol Global located?

Elixinol Global is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

What does Elixinol Global do?

Elixinol Global was founded in 2017 and is based in Sydney, Australia. Operations focus on the nutraceuticals sector, where cannabis-based products are produced. Hemp-derived CBD items are developed for applications in fitness, general health, and stress management. The company maintains a presence in the global wellness market through these specialized offerings.

Who are the top competitors of Elixinol Global?

Elixinol Global's top competitors include Vireo Health, Alphargreen Group Limited and Demetrix.

Is Elixinol Global publicly traded?

Yes, Elixinol Global is publicly traded on ASX under the ticker symbol EXL.

How many acquisitions has Elixinol Global made?

Elixinol Global has made 1 acquisition, including CannaCare Health.

What is Elixinol Global's ticker symbol?

The ticker symbol of Elixinol Global is EXL on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available